FDA Inspection 910554 — Octapharma Plasma, Inc.
The FDA completed an inspection of Octapharma Plasma, Inc. on January 21, 2015 in South Bend, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 21, 2015
- Fiscal Year
- 2015
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- South Bend, IN (United States)